| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.52 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |